Here are the complete answers to your Second Terminal Examination paper, organized exactly as per the mark distribution.
DEPARTMENT OF PHYSIOLOGY
Second Terminal Examination - MBBS Batch 2025-26
Time: 2:40 Hrs | Max. Marks: 80
Q.1 Essay Type Question (5 + 4 + 3 + 3 = 15 marks)
Part A: Diagrams of Ascending Tracts + Differentiation (5 marks)
The ascending (sensory) tracts of the spinal cord carry information from peripheral receptors to the brain. There are two major systems:
1. Dorsal Column - Medial Lemniscal (DCML) Pathway
Receptor → First-order neuron → Dorsal column (same side)
→ Nucleus gracilis / cuneatus (Medulla) → Decussation
→ Medial lemniscus → Thalamus (VPL) → Somatosensory cortex
- Travels IPSILATERALLY in the spinal cord, crosses at the medulla
- Gracile fasciculus (T7 and below); Cuneate fasciculus (T6 and above)
2. Spinothalamic Tract (Anterolateral Pathway)
Receptor → First-order neuron → Dorsal horn synapse
→ Decussation (within 1-2 segments) → Contralateral anterolateral column
→ Thalamus (VPL) → Somatosensory cortex
- Crosses at the SPINAL CORD LEVEL (near entry)
3. Spinocerebellar Tracts
- Anterior (Gower's tract): Crosses twice - ipsilateral representation
- Posterior (Flechsig's tract): Uncrossed, travels in posterolateral column
Diagram (Spinal cord cross-section):
POSTERIOR
[Dorsal columns]
[ G | C ]
/ \
[SCT post] [SCT ant]
\ /
[SThT] [CST desc]
ANTERIOR
G = Gracile; C = Cuneate; SCT = Spinocerebellar; SThT = Spinothalamic
Differentiation Table:
| Feature | DCML | Spinothalamic | Spinocerebellar |
|---|
| Location | Posterior column | Anterolateral | Posterolateral / Anterior |
| Decussation | At medulla | At spinal cord | Does not cross (posterior) |
| 1st synapse | Medulla | Dorsal horn | Dorsal horn (Clarke's nucleus) |
| 2nd synapse | Thalamus (VPL) | Thalamus (VPL) | Cerebellum (no thalamus) |
Part B: Sensations Carried (4 marks)
| Tract | Sensations Carried |
|---|
| Dorsal Column (DCML) | Fine/discriminative touch, proprioception, vibration sense, two-point discrimination, stereognosis, graphesthesia |
| Lateral Spinothalamic | Pain and temperature (crude) |
| Anterior Spinothalamic | Crude touch, pressure, tickle |
| Posterior Spinocerebellar | Unconscious proprioception from lower limbs (muscle spindles, GTO) |
| Anterior Spinocerebellar | Unconscious proprioception from lower limbs (GTO predominantly) |
| Spinoreticular | Diffuse, poorly localized pain (arousal component) |
Part C: Brown-Sequard Syndrome (3 marks)
Definition: Hemisection (half-section) of the spinal cord resulting in a characteristic pattern of ipsilateral and contralateral deficits below the level of lesion.
Classic Features (e.g., Right-sided lesion at T5):
| Feature | Side | Mechanism |
|---|
| Ipsilateral spastic paralysis (UMN) | Right (same side) | Corticospinal tract is ipsilateral below decussation in medulla |
| Ipsilateral loss of fine touch, vibration, proprioception | Right (same side) | DCML crosses at medulla, so cord injury = ipsilateral loss |
| Contralateral loss of pain and temperature | Left (opposite side) | Spinothalamic tract crosses within 1-2 segments of entry |
| Ipsilateral LMN signs at lesion level | Right, at T5 only | Anterior horn cell damage at that segment |
| Ipsilateral vasodilation/anhidrosis | Right | Disruption of descending autonomic fibers |
Causes: Penetrating trauma (stab wound), MS, cord tumors, disc herniation, radiation myelopathy.
Note: Pure hemisection is rare; "Brown-Sequard Plus" (incomplete variant) is more common in clinical practice.
Q.2 Clinical Case Scenario (1 + 3 + 6 + 3 + 2 = 15 marks)
Case: 50-year-old obese male with weakness, polydipsia, polyuria, polyphagia, weight loss, delayed wound healing. FBG: 170 mg/dl; HbA1c: 7.9%; LDL: 140 mg/dl.
Part (a): Probable Diagnosis (1 mark)
Type 2 Diabetes Mellitus (T2DM)
Rationale: FBG ≥ 126 mg/dl (here 170 mg/dl) + HbA1c ≥ 6.5% (here 7.9%) in an obese middle-aged male with the classic triad of polyuria, polydipsia, polyphagia, plus weight loss and impaired healing.
Part (b): Physiological Basis of Symptoms (3 marks)
| Symptom | Physiological Basis |
|---|
| Polyuria | Hyperglycemia exceeds renal threshold (~180 mg/dl) → glucose spills into urine → osmotic diuresis → increased urine output |
| Polydipsia (Increased thirst) | Osmotic diuresis → dehydration → rise in plasma osmolarity → stimulates osmoreceptors in hypothalamus → ADH release + thirst |
| Polyphagia (Increased appetite) | Lack of insulin signaling → cells cannot uptake glucose → "cellular starvation" despite high blood glucose → hypothalamus signals hunger |
| Weight loss | Insulin deficiency → decreased glucose uptake → increased lipolysis (fat breakdown) + protein catabolism → net weight loss |
| Weakness | Inadequate glucose delivery to muscles → reduced energy production (ATP) → weakness and fatigue |
| Delayed wound healing | Impaired leukocyte function (reduced chemotaxis, phagocytosis), microvascular disease reducing blood supply, reduced collagen synthesis → poor healing |
Part (c): Functions of Insulin (6 marks)
Insulin is a polypeptide hormone secreted by beta cells of islets of Langerhans. It is the primary anabolic hormone of the body.
I. Effects on Carbohydrate Metabolism (2 marks)
- Increases GLUT-4 mediated glucose uptake by muscle and adipose tissue
- Stimulates glycogenesis (glucose → glycogen) in liver and muscle
- Inhibits gluconeogenesis and glycogenolysis in liver
- Stimulates glycolysis (glucose oxidation for energy)
- Net effect: Lowers blood glucose
II. Effects on Fat Metabolism (2 marks)
- Stimulates lipogenesis (triglyceride synthesis) in adipose tissue
- Inhibits hormone-sensitive lipase → inhibits lipolysis
- Increases LPL (lipoprotein lipase) activity → increases fat storage
- Inhibits ketogenesis
- Net effect: Anti-lipolytic and pro-lipogenic
III. Effects on Protein Metabolism (1 mark)
- Stimulates amino acid uptake by cells
- Stimulates protein synthesis (anabolic effect)
- Inhibits protein catabolism and gluconeogenesis from amino acids
- Net effect: Positive nitrogen balance, promotes growth
IV. Other Effects (1 mark)
- Promotes K+ uptake into cells (hypokalemia in excess insulin)
- Stimulates cell growth and proliferation
- Promotes sodium and water retention (contributes to hypertension in insulin resistance)
- Stimulates hypothalamic satiety centers
Part (d): Oral Glucose Tolerance Test (OGTT) (3 marks)
Definition: A standard test to assess body's ability to metabolize glucose after an oral glucose load.
Procedure:
- Patient fasts for 8-14 hours overnight
- Fasting blood glucose measured (baseline)
- 75 g of glucose dissolved in 250-300 mL water is given orally
- Blood glucose measured at 30 min, 1 hour, and 2 hours post-ingestion
Interpretation (WHO criteria):
| Result | Fasting | 2-hour Post-Load |
|---|
| Normal | < 100 mg/dl | < 140 mg/dl |
| Impaired Fasting Glucose | 100-125 mg/dl | - |
| Impaired Glucose Tolerance (Pre-diabetes) | - | 140-199 mg/dl |
| Diabetes Mellitus | ≥ 126 mg/dl | ≥ 200 mg/dl |
Clinical Use:
- Diagnosis of T2DM and gestational diabetes
- Diagnosis of pre-diabetes (IGT/IFG)
- Screening in high-risk populations (obese, family history, hypertensive)
- In pregnancy: 75g OGTT at 24-28 weeks (Carpenter-Coustan criteria)
Normal OGTT curve: Peak at 30-60 min, returns to baseline by 2 hours.
Part (e): Metabolic Syndrome (2 marks)
Definition: A cluster of metabolic abnormalities that together significantly increase the risk of cardiovascular disease and T2DM.
Diagnostic Criteria (IDF / NCEP-ATP III - requires any 3 of 5):
| Component | Threshold |
|---|
| Central obesity | Waist circumference >102 cm (men) / >88 cm (women); BMI >30 kg/m² |
| Elevated fasting blood glucose | ≥ 100 mg/dl OR on diabetes treatment |
| Hypertension | ≥ 130/85 mmHg OR on antihypertensive treatment |
| Low HDL cholesterol | < 40 mg/dl (men) / < 50 mg/dl (women) |
| Elevated triglycerides | ≥ 150 mg/dl OR on lipid-lowering treatment |
Pathophysiology: Central (visceral) obesity → insulin resistance → compensatory hyperinsulinemia → hypertension, dyslipidemia, hyperglycemia.
This patient meets criteria: obese + elevated FBG (170) + elevated LDL → likely also has other components.
Q.3 Short Notes (6 × 5 = 30 marks)
(a) Types of Hypoxia (5 marks)
Definition: Hypoxia is a condition in which the oxygen supply to tissues is inadequate for their metabolic needs.
Classification and Differentiation:
| Type | Definition | PaO₂ | O₂ Saturation | O₂ Content | A-V O₂ diff | Example |
|---|
| Hypoxic (Hypoxemia) | Reduced PaO₂ due to inadequate oxygenation in lungs | Low | Low | Low | Increased | High altitude, hypoventilation, COPD, V/Q mismatch |
| Anemic | Normal PaO₂ but reduced O₂-carrying capacity (low Hb) | Normal | Normal | Low | Increased | Anemia, CO poisoning, methemoglobinemia |
| Stagnant (Ischemic) | Normal O₂ content but reduced blood flow/delivery | Normal | Normal | Normal | Increased | Heart failure, shock, local ischemia |
| Histotoxic | Tissues unable to utilize O₂ despite normal delivery | Normal | Normal | Normal | Decreased (venous O₂ high) | Cyanide poisoning (blocks cytochrome oxidase) |
| Demand hypoxia | O₂ demand exceeds supply during extreme exercise | Normal/Low | Normal/Low | Normal | Increased | Strenuous exercise |
Key differentiating point: In histotoxic hypoxia, venous PO₂ is HIGH (oxygen not being used), unlike all others where venous O₂ is low.
Affinity hypoxia (additional type): CO poisoning shifts O₂-Hb curve left, preventing O₂ unloading at tissues.
(b) Visual Pathway with Lesions (5 marks)
Pathway:
Retina → Optic Nerve (CN II) → Optic Chiasm → Optic Tract
→ Lateral Geniculate Nucleus (LGN) of Thalamus
→ Optic Radiation (Geniculocalcarine tract)
→ Primary Visual Cortex (Area 17, Calcarine sulcus, Occipital lobe)
Key anatomical note: Nasal (medial) fibers decussate at the optic chiasm; Temporal (lateral) fibers remain ipsilateral.
Lesions and Visual Field Defects:
| Site of Lesion | Visual Defect | Example Cause |
|---|
| 1. Optic nerve | Monocular blindness (same eye) | Optic neuritis, trauma |
| 2. Optic chiasm (central) | Bitemporal hemianopia ("tunnel vision") | Pituitary adenoma, craniopharyngioma |
| 3. Optic tract | Contralateral homonymous hemianopia (incongruous) | Trauma, tumor |
| 4. Meyer's loop (temporal lobe) | Contralateral superior quadrantanopia ("pie in the sky") | Temporal lobe tumor |
| 5. Parietal optic radiation | Contralateral inferior quadrantanopia ("pie on the floor") | Parietal lobe tumor |
| 6. Visual cortex (complete) | Contralateral homonymous hemianopia WITH macular sparing | MCA/PCA infarct |
Diagram representation:
LEFT EYE RIGHT EYE
[L] [N] [N] [R]
↓ ↓
[Optic Nerve] [Optic Nerve]
↓
[Optic Chiasm] ← Nasal fibers cross
↓
[L Optic Tract] [R Optic Tract]
↓ ↓
[LGN] [LGN]
↓ ↓
[Optic Radiation] [Optic Radiation]
↓ ↓
[L Visual Cortex] [R Visual Cortex]
(c) Functions of Gastrin, Cholecystokinin (CCK), and Secretin (5 marks)
1. GASTRIN
- Source: G cells of antrum of stomach + duodenum
- Stimulus: Protein/peptides in stomach, vagal stimulation, gastric distension, hypercalcemia
- Functions:
- Stimulates HCl secretion by parietal cells (main function)
- Stimulates pepsinogen secretion by chief cells
- Promotes gastric motility
- Trophic (growth) effect on gastric mucosa
- Stimulates insulin secretion
- Inhibited by: pH < 3.0 (negative feedback), somatostatin, secretin
2. CHOLECYSTOKININ (CCK)
- Source: I cells of duodenum and jejunum
- Stimulus: Fat and protein (digestion products) in duodenum
- Functions:
- Gallbladder contraction and bile release (main function)
- Relaxation of sphincter of Oddi
- Stimulates pancreatic enzyme secretion (amylase, lipase, proteases)
- Augments action of secretin on pancreatic bicarbonate
- Inhibits gastric emptying (slows entry of food into duodenum)
- Satiety signal to hypothalamus (reduces appetite)
3. SECRETIN
- Source: S cells of duodenum
- Stimulus: Acid (low pH) entering duodenum from stomach; fat
- Functions:
- Stimulates pancreatic ductal cells to secrete bicarbonate-rich juice (main function - neutralizes acidic chyme)
- Stimulates liver to secrete bile (volume, not composition)
- Inhibits gastric HCl secretion
- Inhibits gastric motility and emptying
- Augments CCK-stimulated pancreatic enzyme secretion
(d) Properties of Synapse (Any 4) (5 marks)
A synapse is the specialized junction between two neurons (or neuron and effector) where signal transmission occurs.
1. Unidirectional Transmission
- Impulses travel only from pre-synaptic to post-synaptic neuron (orthodromic transmission)
- Due to the presence of neurotransmitter vesicles only in the pre-synaptic terminal and receptors only on post-synaptic membrane
- Prevents feedback/reverse conduction
2. Synaptic Delay
- A delay of 0.5-1 ms occurs at each synapse
- This is the time required for: Ca²+ influx → vesicle fusion → NT release → NT diffusion → receptor binding → generation of EPSP/IPSP
- Total delay in a reflex arc can be estimated from number of synapses × 0.5 ms
3. Summation
- A single EPSP is usually insufficient to generate an action potential
- Temporal summation: Rapid successive impulses from ONE pre-synaptic neuron summate
- Spatial summation: Simultaneous impulses from MULTIPLE pre-synaptic neurons summate
- Both types can reach threshold to fire the post-synaptic neuron
4. Fatigue
- With high-frequency repetitive stimulation, synaptic transmission decreases over time
- Causes: depletion of neurotransmitter vesicles, desensitization of post-synaptic receptors, accumulation of metabolic waste
- Protective mechanism: prevents overexcitation of target neurons
5. Convergence and Divergence (bonus)
- Convergence: Multiple pre-synaptic neurons synapse on a single post-synaptic neuron (integration)
- Divergence: One pre-synaptic neuron synapses on multiple post-synaptic neurons (amplification)
(e) Disorders of Glucocorticoid Hyper- and Hyposecretion (5 marks)
HYPERSECRETION - Cushing's Syndrome/Disease
Definition: Excess cortisol (the principal glucocorticoid) from any cause.
Causes:
- Cushing's Disease: Pituitary adenoma secreting excess ACTH (most common, 70%)
- Ectopic ACTH syndrome: Small cell lung cancer, carcinoid tumors
- Adrenal tumor: Cortisol-secreting adrenal adenoma/carcinoma
- Iatrogenic: Long-term corticosteroid therapy (most common overall cause)
Clinical Features (due to excess cortisol):
| Feature | Mechanism |
|---|
| Central obesity, moon face, buffalo hump | Redistribution of fat to trunk |
| Hyperglycemia ("steroid diabetes") | Increased gluconeogenesis, insulin resistance |
| Muscle wasting, proximal myopathy | Protein catabolism |
| Osteoporosis | Inhibition of osteoblasts, increased Ca²+ excretion |
| Hypertension | Na⁺ and water retention (mineralocorticoid effect) |
| Striae (purple) | Skin fragility from protein catabolism |
| Immunosuppression | Anti-inflammatory, reduced lymphocytes |
| Mood changes, psychosis | Direct CNS effect |
| Hirsutism, menstrual irregularities | Excess adrenal androgens (if ACTH excess) |
HYPOSECRETION - Addison's Disease (Primary Adrenocortical Insufficiency)
Definition: Destruction or dysfunction of the adrenal cortex leading to deficiency of cortisol AND aldosterone.
Causes: Autoimmune (80%, commonest), TB (historical), HIV, bilateral adrenalectomy, adrenal hemorrhage (Waterhouse-Friderichsen syndrome - meningococcemia)
Clinical Features:
| Feature | Mechanism |
|---|
| Weakness, fatigue | Lack of cortisol → reduced gluconeogenesis → hypoglycemia |
| Hyperpigmentation (hallmark of Addison's) | Low cortisol → elevated ACTH + MSH → melanocyte stimulation |
| Hypotension | Aldosterone deficiency → Na⁺ and water loss |
| Hyponatremia, hyperkalemia | Aldosterone deficiency |
| Anorexia, nausea, vomiting | Non-specific GI symptoms |
| Salt craving | Aldosterone deficiency |
| Addisonian crisis | Acute cortisol deficiency → life-threatening hypotension, shock |
Note: Secondary adrenal insufficiency (pituitary ACTH deficiency) does NOT cause hyperpigmentation (ACTH is low) and does NOT cause hyperkalemia (aldosterone axis intact).
Q.4 Short Answer Type Questions (4 × 5 = 20 marks)
(a) Methods of Measurement of Cardiac Output (5 marks)
Normal CO: 5 L/min (at rest); Cardiac Index = CO/BSA = 2.5-4.0 L/min/m²
1. Fick's Principle (Direct Fick Method)
- Formula: CO = O₂ consumed per min / (Arterial O₂ content - Venous O₂ content)
- Requires: Spirometry (O₂ consumption), arterial blood gas, and mixed venous blood from pulmonary artery
- Gold standard, but invasive
2. Indicator Dilution Method
- A known amount of dye (e.g., Evans Blue/Indocyanine green) or cold saline is injected into a vein
- Concentration measured over time in arterial blood
- Stewart-Hamilton equation: CO = Amount of indicator / (Mean concentration × Time of passage)
- Thermodilution (most common clinical method): cold saline injected into right atrium via Swan-Ganz catheter; temperature drop measured in pulmonary artery
3. Echocardiography (Doppler method)
- Stroke volume estimated from: SV = Cross-sectional area of LVOT × Velocity-Time Integral (VTI)
- CO = SV × Heart rate
- Non-invasive, widely used
4. Impedance Cardiography (Bioimpedance)
- Measures changes in thoracic electrical impedance with each heartbeat
- Non-invasive, correlates with CO changes
- Less accurate in obese patients, arrhythmias
5. Pulse Contour Analysis
- Analyses the arterial pressure waveform to estimate SV and CO
- Less invasive than thermodilution
- e.g., PiCCO, LiDCO systems
(b) Referred Pain and Its Theories (5 marks)
Definition: Referred pain is pain perceived at a site different from the actual site of tissue damage or noxious stimulation. It is typically visceral pain referred to a somatic (cutaneous) area.
Classical Examples:
- Cardiac ischemia → Left arm, jaw, left shoulder pain
- Appendicitis → Umbilical region (T10 dermatome) initially
- Diaphragmatic irritation → Shoulder tip (C3,4,5 - phrenic nerve)
- Renal colic → Groin/testis
- Gallbladder → Right shoulder
Theories:
1. Convergence-Projection Theory (most widely accepted)
- Visceral and somatic afferents from the same spinal segment converge on the SAME second-order neuron in the dorsal horn
- The brain, which is accustomed to pain signals from the skin (somatic), "projects" the pain to that somatic area
- It CANNOT distinguish the true source (visceral) from the familiar source (skin)
2. Convergence-Facilitation Theory (MacKenzie's theory)
- Visceral pain impulses create a "facilitated" (hyperexcitable) state in dorsal horn neurons
- Normal, sub-threshold somatic inputs from the referred zone now become suprathreshold
- Even mild somatic stimuli produce pain in the referred area
- Explains cutaneous hyperalgesia and allodynia in referred pain zones
3. Axon Reflex Theory
- Visceral pain impulse travels along peripheral axon → reaches a branch point → antidromic signal travels down somatic branch → releases substance P and other mediators in skin → local inflammation → somatic pain
(c) Difference Between Pituitary Dwarfism and Thyroid Dwarfism (5 marks)
| Feature | Pituitary Dwarfism (GH Deficiency) | Thyroid Dwarfism (Cretinism - Hypothyroid) |
|---|
| Cause | Deficiency of Growth Hormone (GH) from anterior pituitary | Deficiency of thyroid hormones (T3/T4) during fetal/early postnatal life |
| Body proportions | NORMAL proportions (proportionate dwarfism) - head, trunk, limbs all uniformly small | DISPROPORTIONATE - short stature with large head, short limbs, protruding tongue |
| Mental status | Normal intelligence | Severe mental retardation (irreversible if untreated early) |
| Bone age | Delayed but proportionate | Very significantly delayed (stippled epiphyses) |
| Facial features | Normal (may have mild baby-face appearance) | Coarse facies, large tongue (macroglossia), depressed nasal bridge, hypertelorism |
| Metabolic rate | Normal BMR | Low BMR; cold intolerance, sluggishness, constipation |
| Sexual development | Delayed puberty (unless combined gonadotropin deficiency) | Delayed; may have precocious puberty (Van Wyk-Grumbach syndrome) |
| Skin/Hair | Normal | Dry, rough skin; coarse hair; myxedematous (non-pitting edema) |
| Muscle tone | Normal | Hypotonia, umbilical hernia |
| Treatment | GH replacement | Thyroid hormone replacement (must be started EARLY - before 3 months to prevent mental retardation) |
| TSH level | Normal (or elevated ACTH) | Elevated TSH (in primary hypothyroidism) |
| Insulin-like growth factor (IGF-1) | Low | Normal range |
(d) Phantom Limb (5 marks)
Definition: Phantom limb is the perception that an amputated or deafferented limb is still present and is part of the body. It occurs in virtually all amputees (60-80%).
Two components:
- Phantom sensation: Non-painful awareness of the absent limb's presence, position, or movement
- Phantom limb pain: Painful sensations (burning, cramping, shooting) perceived in the absent limb (60-80% of amputees)
Mechanism / Theories:
1. Peripheral Theory
- Neuromas (tangles of regenerating axons) form at the amputation stump
- They discharge spontaneously → sent to brain → interpreted as sensation from missing limb
- Supported by: local anesthetic injection to stump reduces phantom pain temporarily
2. Spinal (Central Sensitization) Theory
- Loss of normal afferent input → spinal neurons become hyperexcitable
- Dorsal horn neurons show "wind-up" and sensitization
- Supported by: phantom pain persists even after dorsal rhizotomy in some cases
3. Cortical Reorganization Theory (most accepted today)
- The somatosensory cortex (Penfield's homunculus) undergoes reorganization after limb loss
- Adjacent cortical areas "invade" the deafferented cortical zone
- Example: Face area expands into the arm area of S1 cortex → touching face triggers phantom arm sensation
- Supported by: neuroimaging (fMRI) studies
Clinical Features:
- Most common in arm and leg amputees
- May feel limb in abnormal position (e.g., twisted), causing distress
- Telescoping: Phantom limb feels as if it is shrinking/retracting into the stump
Treatment:
- Mirror therapy (most effective non-pharmacological)
- Prosthesis use
- TENS (transcutaneous electrical nerve stimulation)
- Pharmacological: Gabapentin, pregabalin, amitriptyline, opioids
- Graded motor imagery
(e) Impedance Matching (5 marks)
Definition: Impedance matching is the process by which the middle ear efficiently transfers sound energy (vibrations) from the low-impedance air medium to the high-impedance fluid (perilymph) of the inner ear, preventing massive energy loss.
The Problem:
- Sound travels through air (low acoustic impedance) to fluid (perilymph, high acoustic impedance)
- At an air-fluid interface, ~99.9% of sound energy is reflected (only 0.1% transmitted) - a 30 dB loss
- The middle ear overcomes this via three mechanisms:
Mechanisms of Impedance Matching:
1. Area Ratio of Tympanic Membrane to Oval Window (most important)
- Tympanic membrane area: ~55 mm²
- Footplate of stapes (oval window): ~3.2 mm²
- Ratio ≈ 17:1
- Force concentrated from large area to small area → pressure amplified ~17-fold
2. Lever Action of the Ossicular Chain
- Malleus, Incus, Stapes form a lever system
- Effective lever ratio: ~1.3:1
- Additional force amplification
3. Buckling Effect of the Tympanic Membrane
- The curved tympanic membrane buckles like a drum membrane
- Additional mechanical advantage ≈ 2-fold
Total Amplification:
- Overall pressure gain = 17 × 1.3 × 2 ≈ 44-fold (about 25-30 dB)
- This nearly compensates for the theoretical 30 dB loss at the air-fluid interface
Clinical Relevance:
- Damage to the ossicular chain (otosclerosis, trauma) → Conductive hearing loss
- Otosclerosis: Fixation of stapes footplate → impedance mismatch → up to 60 dB conductive loss
- Tympanoplasty/ossiculoplasty: Surgical procedures to restore impedance matching
- Acoustic reflex: Tensor tympani and stapedius muscles contract to stiffen the system → reduces transmission of loud sounds (protective mechanism)
All answers compiled from Guyton & Hall Medical Physiology, Gray's Anatomy for Students, Harrison's Principles of Internal Medicine, and Costanzo Physiology.